Public preview. Funding rounds, founders, and growth signals require a free account.

Anagin, Inc.

Develops novel therapies targeting disrupted synaptic plasticity for neuropsychiatric disorders like PTSD, TBI, depression, and Alzheimer's.

Series APharmaIndianapolis, IN

Total raised

$5.3M

Last round

Equity

$1.3M · Jun 2018

Stage

Series A

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment Anagin, Inc. files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.